{
  "url": "https://openlegislation.uk/medicines-products-for-human-use-fees-amendment-regulations-2023/regulation-15",
  "json_url": "https://openlegislation.uk/medicines-products-for-human-use-fees-amendment-regulations-2023/regulation-15.json",
  "legislation": "uksi/2023/314",
  "legislation_title": "The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2023",
  "legislation_url": "https://openlegislation.uk/medicines-products-for-human-use-fees-amendment-regulations-2023",
  "path": "regulation/15",
  "kind": "regulation",
  "number": "15",
  "heading": "Amendment of regulation 19C",
  "text": "In regulation 19C (fees for assessment of post-authorisation safety studies)—\n(a) in paragraph (2)—\n(i) in sub-paragraph (a), for “£734” substitute “£1,308”,\n(ii) in sub-paragraph (b), for “£8,309” substitute “£9,140”,\n(iii) in sub-paragraph (c), for “£734” substitute “£1,308”, and\n(b) in paragraph (3)—\n(i) in sub-paragraph (a), for “£734” substitute “£1,308”,\n(ii) in sub-paragraph (b), for “£8,309” substitute “£9,140”, and\n(iii) in sub-paragraph (c), for “£734” substitute “£1,308”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "Inserted by S.I. 2019/775 (as amended by S.I. 2020/1488)."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2023/314/regulation/15",
    "retrieved_at": "2026-10-28T21:47:53.846751+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}